Showing results (491-500 of 1,120) with videos related to

Sort By:
Pageof 112
American Heart Journal|April 26, 2022
ReducinG stroke by screening for UndiAgnosed atRial fibrillation in elderly inDividuals (GUARD-AF): Rationale and design of the GUARD-AF randomized trial of screening for atrial fibrillation with a 14-day patch-based continuous ECG monitorDaniel E Singer, Steven J Atlas, Alan S Go, et al.
Microscopy Research and Technique|August 25, 2010
Microscopic evidences that bone marrow mononuclear cell treatment improves sciatic nerve regeneration after neurorrhaphyJoão D Lopes-Filho, Heloisa C Caldas, Fernanda C A Santos, et al.
European Journal of Preventive Cardiology|November 27, 2024
Albiglutide and atrial fibrillation in patients with type 2 diabetes and established cardiovascular disease - insights from the Harmony Outcomes trialKonstantin A Krychtiuk, Guillaume Marquis-Gravel, Shannon Murphy, et al.
Journal of the American Heart Association|January 12, 2021
Gaps in Evidence-Based Therapy Use in Insured Patients in the United States With Type 2 Diabetes Mellitus and Atherosclerotic Cardiovascular DiseaseAdam J Nelson, Maddalena Ardissino, Kevin Haynes, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|July 18, 2023
Plasma angiopoietin-2 and its association with heart failure in patients with atrial fibrillationAlexander P Benz, Ziad Hijazi, Johan Lindbäck, et al.
Circulation|September 28, 2014
Saphenous vein graft failure after coronary artery bypass surgery: insights from PREVENT IVConnie N Hess, Renato D Lopes, C Michael Gibson, et al.
International Journal of Cardiology|October 9, 2015
Chronic obstructive pulmonary disease in patients with atrial fibrillation: Insights from the ARISTOTLE trialMichael T Durheim, Derek D Cyr, Renato D Lopes, et al.
American Heart Journal|October 17, 2012
Antithrombotic therapy for atrial fibrillation and coronary artery disease in older patientsConnie N Hess, Samuel Broderick, Jonathan P Piccini, et al.
Circulation|March 13, 2020
Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Advanced Chronic Kidney DiseaseJohn W Stanifer, Sean D Pokorney, Glenn M Chertow, et al.
Circulation|November 15, 2021
Efpeglenatide and Clinical Outcomes With and Without Concomitant Sodium-Glucose Cotransporter-2 Inhibition Use in Type 2 Diabetes: Exploratory Analysis of the AMPLITUDE-O TrialCarolyn S P Lam, Chinthanie Ramasundarahettige, Kelley R H Branch, et al.
Pageof 112